{
    "clinical_study": {
        "@rank": "141137", 
        "arm_group": [
            {
                "arm_group_label": "Acetate-free solution first", 
                "arm_group_type": "Experimental", 
                "description": "Acetate-free solution first : hemodialysis 4 hours with Acetate-free solution (Acetate 0 mEq/L Citrate 2 mEq/L) at the first session after enrollment, and then switch to Acetate-based solution (Acetate 3 mEq/L Citrate 0 mEq/L) at the next 4-hr hemodialysis session"
            }, 
            {
                "arm_group_label": "Acetate-based solution first", 
                "arm_group_type": "Active Comparator", 
                "description": "Acetate-based solution first : hemodialysis 4 hours with Acetate-based solution (Acetate 3 mEq/L Citrate 0 mEq/L) at the first session after enrollment, and then switch to Acetate-free solution (Acetate 2 mEq/L Citrate 2 mEq/L) at the next 4-hr hemodialysis session"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to detemine whether effect of Acetate-free solution on cardiac\n      index and cardiac output measured by saline dilution techniques compares with Acetate-based\n      solution in online-hemodiafiltration"
        }, 
        "brief_title": "Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "End-stage Renal Disease", 
        "condition_browse": {
            "mesh_term": [
                "Kidney Diseases", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  End-stage renal disease patients with age over 20 years and stable clinical status\n\n          -  Dialytic age > 6 months\n\n          -  Maintenance hemodialysis with online-hemodiafiltration mode at King Chulalongkorn\n             Memorial Hospital\n\n          -  Use arteriovenous fistula or arteriovenous graft as vascular access for hemodialysis\n\n          -  No vascular access recirculation\n\n          -  No liver impairment\n\n          -  No severe, intractable metabolic acidosis or alkalosis (HCO3 <15, >30)\n\n          -  No pre-existing severe, intractable hypocalcemia (Ca < 7.5) or clinical of\n             hypocalcemia\n\n        Exclusion Criteria:\n\n          -  On hemodialysis via tunnel catheter\n\n          -  Vascular access recirculation\n\n          -  Liver dysfunction\n\n          -  Severe, intractable metabolic acidosis or alkalosis (HCO3 <15, >30)\n\n          -  Pre-existing severe, intractable hypocalcemia (Ca < 7.5) or clinical of hypocalcemia\n\n          -  Acute or recent myocardial ischemia or congestive heart failure (within 1 months)\n\n          -  Threatening arrhythmia (VT, VF, sustained SVT, AF with rapid ventricular response)\n\n          -  Patients affected by acute or chronic infections, malignant tumor"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "22", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01778283", 
            "org_study_id": "297/55"
        }, 
        "intervention": {
            "arm_group_label": [
                "Acetate-free solution first", 
                "Acetate-based solution first"
            ], 
            "description": "the hemodialysis solution that does not contain acetate as buffer", 
            "intervention_name": "Acetate-free dialysis solution", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "February 12, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10330"
                }, 
                "name": "Faculty of Medicine, Chulalongkorn University"
            }
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration", 
        "other_outcome": {
            "description": "BUN, creatinine, serum sodium, serum potassium, serum bicarbonate, serum calcium, ionized calcium, serum magnesium, serum osmol, troponin T, NT-proBNP, CKMB, hs-CRP", 
            "measure": "cardiac marker, serum electrolyte, inflammatory marker", 
            "safety_issue": "Yes", 
            "time_frame": "January 2013"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "cardiac index and cardiac output was measured by ultrasound dilution technique", 
                "measure": "cardiac index", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "cardiac index and cardiac output was measured by ultrasound dilution technique", 
                "measure": "Cardiac output", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01778283"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chulalongkorn University", 
            "investigator_full_name": "Khajohn Tiranathanagul", 
            "investigator_title": "Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "peripheral vascular resistance", 
                "safety_issue": "Yes", 
                "time_frame": "6 moths"
            }, 
            {
                "description": "dizziness, palpitation, nausea, cramp, numbness", 
                "measure": "Patients' symptoms", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Chulalongkorn University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chulalongkorn University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}